16,836 Shares in UnitedHealth Group Incorporated (NYSE:UNH) Acquired by Aurora Private Wealth Inc.

Aurora Private Wealth Inc. purchased a new stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) in the 1st quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm purchased 16,836 shares of the healthcare conglomerate's stock, valued at approximately $8,818,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. MOKAN Wealth Management Inc. grew its holdings in shares of UnitedHealth Group by 17.3% in the first quarter. MOKAN Wealth Management Inc. now owns 5,361 shares of the healthcare conglomerate's stock valued at $2,807,000 after purchasing an additional 790 shares during the period. waypoint wealth counsel lifted its holdings in UnitedHealth Group by 21.4% in the first quarter. waypoint wealth counsel now owns 1,082 shares of the healthcare conglomerate's stock valued at $567,000 after acquiring an additional 191 shares during the last quarter. Adams Diversified Equity Fund Inc. increased its stake in UnitedHealth Group by 56.8% during the first quarter. Adams Diversified Equity Fund Inc. now owns 50,800 shares of the healthcare conglomerate's stock worth $26,606,000 after acquiring an additional 18,400 shares during the last quarter. Mattern Capital Management LLC grew its holdings in shares of UnitedHealth Group by 2.5% during the 1st quarter. Mattern Capital Management LLC now owns 19,184 shares of the healthcare conglomerate's stock worth $10,048,000 after purchasing an additional 471 shares during the period. Finally, Riverbend Wealth Management LLC lifted its position in UnitedHealth Group by 9.5% in the first quarter. Riverbend Wealth Management LLC now owns 2,573 shares of the healthcare conglomerate's stock valued at $1,347,000 after buying an additional 224 shares during the last quarter. Institutional investors and hedge funds own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several brokerages have recently commented on UNH. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a report on Wednesday, May 14th. JPMorgan Chase & Co. lifted their target price on UnitedHealth Group from $405.00 to $418.00 and gave the company an "overweight" rating in a research report on Friday, June 20th. Baird R W lowered shares of UnitedHealth Group from a "strong-buy" rating to a "hold" rating in a research note on Wednesday, June 11th. Argus cut shares of UnitedHealth Group from a "buy" rating to a "hold" rating in a research report on Monday, April 21st. Finally, HSBC reiterated a "reduce" rating and issued a $270.00 price objective (down from $490.00) on shares of UnitedHealth Group in a research note on Wednesday, May 21st. One research analyst has rated the stock with a sell rating, nine have assigned a hold rating and sixteen have given a buy rating to the stock. According to MarketBeat, UnitedHealth Group currently has an average rating of "Moderate Buy" and an average price target of $415.57.

UnitedHealth Group Price Performance

Shares of UNH traded up $0.41 during trading hours on Thursday, reaching $302.43. The company had a trading volume of 6,497,799 shares, compared to its average volume of 7,416,648. The company has a market capitalization of $274.35 billion, a price-to-earnings ratio of 12.66, a PEG ratio of 1.43 and a beta of 0.44. UnitedHealth Group Incorporated has a 12-month low of $248.88 and a 12-month high of $630.73. The firm has a 50 day simple moving average of $342.22 and a 200-day simple moving average of $458.07. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings data on Thursday, April 17th. The healthcare conglomerate reported $7.20 earnings per share for the quarter, missing the consensus estimate of $7.29 by ($0.09). UnitedHealth Group had a net margin of 5.39% and a return on equity of 26.29%. The firm had revenue of $109.58 billion during the quarter, compared to analysts' expectations of $111.56 billion. During the same period in the previous year, the business earned $6.91 earnings per share. Research analysts expect that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Increases Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, June 24th. Stockholders of record on Monday, June 16th were given a $2.21 dividend. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a dividend yield of 2.92%. UnitedHealth Group's dividend payout ratio is currently 37.02%.

Insider Buying and Selling

In related news, CEO Stephen J. Hemsley acquired 86,700 shares of the company's stock in a transaction that occurred on Friday, May 16th. The stock was purchased at an average price of $288.57 per share, for a total transaction of $25,019,019.00. Following the transaction, the chief executive officer now owns 679,493 shares in the company, valued at $196,081,295.01. This trade represents a 14.63% increase in their position. The purchase was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, CFO John F. Rex purchased 17,175 shares of the firm's stock in a transaction on Friday, May 16th. The shares were purchased at an average cost of $291.12 per share, for a total transaction of $4,999,986.00. Following the completion of the purchase, the chief financial officer now directly owns 203,796 shares in the company, valued at $59,329,091.52. The trade was a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders purchased 109,408 shares of company stock worth $31,607,768 in the last ninety days. Insiders own 0.28% of the company's stock.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.